Por favor, use este identificador para citar o enlazar este ítem: https://doi.org/10.3109/00365548.2012.752859

Título: Cutaneous leishmaniasis in a patient receiving infliximab
Editorial: Taylor and Francis Group
Cita bibliográfica: Scandinavian Journal of Infectious Diseases, 2012; Early Online: 1–3
ISSN: Print.: 2374-4235
Electronic.: 2374-4243
Palabras clave: Leishmania
Cutaneous Leishmaniasis
Tumour necrosis factor antagonists
Infliximab
Resumen: Abstract Leishmaniasis is endemic in the Mediterranean region, and the prevalence of latent infection in this area is high. Treatment with tumour necrosis factor (TNF) antagonists represents a major breakthrough in the treatment of several infl ammatory diseases, including psoriasis. Reports describing opportunistic leishmaniasis in European patients treated with TNF- α antagonist drugs are rapidly accumulating. We describe a case of cutaneous leishmaniasis in a patient treated with infl iximab and corticosteroids.
Autor/es principal/es: Hernández Torres, Alicia
García Vázquez, Elisa
Frías Iniesta, José
Herrero Martínez, José Antonio
Gómez Gómez, Joaquín
Versión del editor: https://www.tandfonline.com/doi/full/10.3109/00365548.2012.752859
URI: http://hdl.handle.net/10201/149908
DOI: https://doi.org/10.3109/00365548.2012.752859
Tipo de documento: info:eu-repo/semantics/article
Número páginas / Extensión: 3
Derechos: info:eu-repo/semantics/embargoedAccess
Descripción: © 2012 Informa Healthcar. This document is the published version of a published work that appeared in final form in Scandinavian Journal of Infectious Diseases. . To access the final edited and published work see: https://doi.org/10.3109/00365548.2012.752859
Aparece en las colecciones:Artículos

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
Articulo LC.pdf127,17 kBAdobe PDFVista previa
Visualizar/Abrir    Solicitar una copia


Los ítems de Digitum están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.